These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25676417)

  • 1. Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.
    Hahn CN; Brautigan PJ; Chong CE; Janssan A; Venugopal P; Lee Y; Tims AE; Horwitz MS; Klingler-Hoffmann M; Scott HS
    Leukemia; 2015 Aug; 29(8):1795-7. PubMed ID: 25676417
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-derived MDS/AML in families with germline
    Galera P; Hsu AP; Wang W; Droll S; Chen R; Schwartz JR; Klco JM; Arai S; Maese L; Zerbe C; Parta MJ; Young NS; Holland SM; Hickstein DD; Calvo KR
    Blood; 2018 Nov; 132(18):1994-1998. PubMed ID: 30232126
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenotypic heterogeneity associated with germline
    Haddox CL; Carr RM; Abraham RS; Perez Botero J; Rodriguez V; Pardanani A; Patnaik MM
    Leuk Lymphoma; 2019 Dec; 60(13):3282-3286. PubMed ID: 31246134
    [No Abstract]   [Full Text] [Related]  

  • 4. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
    Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
    Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline GATA2 Mutation and Bone Marrow Failure.
    McReynolds LJ; Calvo KR; Holland SM
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alert in germline mutation predisposed to myeloid neoplasm: myelodysplastic syndromes accompanied with GATA2 deficeincy syndrome].
    Yao H; Yang X; Zhang X; Wang P; Deng XJ; Luo ML; Chen T; Liu YQ; Feng YM; Gao L; Kong PY
    Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):1042-1045. PubMed ID: 35045679
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
    Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
    Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline ETV6 mutations and predisposition to hematological malignancies.
    Feurstein S; Godley LA
    Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation.
    Kim N; Choi S; Kim SM; Lee AC; Im K; Park HS; Kim JA; Kim K; Kim I; Chang YH; Lee DS
    Leuk Lymphoma; 2019 Apr; 60(4):1053-1061. PubMed ID: 30714451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies.
    Wang X; Muramatsu H; Okuno Y; Sakaguchi H; Yoshida K; Kawashima N; Xu Y; Shiraishi Y; Chiba K; Tanaka H; Saito S; Nakazawa Y; Masunari T; Hirose T; Elmahdi S; Narita A; Doisaki S; Ismael O; Makishima H; Hama A; Miyano S; Takahashi Y; Ogawa S; Kojima S
    Haematologica; 2015 Oct; 100(10):e398-401. PubMed ID: 26022708
    [No Abstract]   [Full Text] [Related]  

  • 11. Granulomatous lung disease in a patient with a family history of hematological disorders.
    Overbeek MJ; van de Loosdrecht AA; Vonk-Noordegraaf A
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):350-3. PubMed ID: 25591147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML.
    Al Seraihi AF; Rio-Machin A; Tawana K; Bödör C; Wang J; Nagano A; Heward JA; Iqbal S; Best S; Lea N; McLornan D; Kozyra EJ; Wlodarski MW; Niemeyer CM; Scott H; Hahn C; Ellison A; Tummala H; Cardoso SR; Vulliamy T; Dokal I; Butler T; Smith M; Cavenagh J; Fitzgibbon J
    Leukemia; 2018 Nov; 32(11):2502-2507. PubMed ID: 29749400
    [No Abstract]   [Full Text] [Related]  

  • 13. A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability.
    Fox LC; Tan M; Brown AL; Arts P; Thompson E; Ryland GL; Lickiss J; Scott HS; Poplawski NK; Phillips K; Came NA; James P; Ting SB; Ritchie DS; Szer J; Hahn CN; Schwarer A; Blombery P
    Br J Haematol; 2020 Sep; 190(5):e297-e301. PubMed ID: 32488879
    [No Abstract]   [Full Text] [Related]  

  • 14. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.
    Hahn CN; Chong CE; Carmichael CL; Wilkins EJ; Brautigan PJ; Li XC; Babic M; Lin M; Carmagnac A; Lee YK; Kok CH; Gagliardi L; Friend KL; Ekert PG; Butcher CM; Brown AL; Lewis ID; To LB; Timms AE; Storek J; Moore S; Altree M; Escher R; Bardy PG; Suthers GK; D'Andrea RJ; Horwitz MS; Scott HS
    Nat Genet; 2011 Sep; 43(10):1012-7. PubMed ID: 21892162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
    Pasquet M; Bellanné-Chantelot C; Tavitian S; Prade N; Beaupain B; Larochelle O; Petit A; Rohrlich P; Ferrand C; Van Den Neste E; Poirel HA; Lamy T; Ouachée-Chardin M; Mansat-De Mas V; Corre J; Récher C; Plat G; Bachelerie F; Donadieu J; Delabesse E
    Blood; 2013 Jan; 121(5):822-9. PubMed ID: 23223431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
    Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
    Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
    Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
    Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
    Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of GATA2-related myeloid neoplasms.
    Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
    Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.